Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rahul Katyal (Chandigarh, India), Rahul Katyal, Ashok Janmeja, Vivek Ku. Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients. Eur Respir J 2015; 46: Suppl. 59, 3689

Member's Comments

No comment yet.

Related content which might interest you: Predicting progression of RA-ILD using anti-CCP Source: International Congress 2015 – Connective tissue disorders Year: 2015 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Red blood cell distribution with in patients With chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI) Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Red blood cell distribution width in patients with chronic obstructive lung disease:how is changed in exacerbation? Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Correlation between red cell distribution width and disease severity and mortality in COPD patients Source: International Congress 2014 – COPD exacerbations Year: 2014 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy Source: International Congress 2014 – ILDs 4 Year: 2014 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Telomere (TL) shortening is associated with disease severity in scleroderma (SSC) associated interstitial lung disease (ILD) Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis Source: International Congress 2016 – Connective tissue disorders Year: 2016